Diana Shaw of Wiley Rein LLP examines a recent HHS Office of Inspector General advisory on direct-to-consumer prescription ...
Where FDA breakthrough devices stand through 2025: growth, authorizations, leading specialties, AI trends, and qualification pathways explained.
Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...
The PRPS guidelines provide a uniform foundation across government regulators to reduce illness and outbreaks related to produce.
A physician who specializes in HIV treatment writes that proposed cuts to an AIDS drug program proposed by the Florida Dept.
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...